Eton Pharmaceuticals (ETON) Gains from Investment Securities (2018)

Eton Pharmaceuticals (ETON) has 1 years of Gains from Investment Securities data on file, last reported at $1.5 million in Q4 2018.

• For the quarter ending Q4 2018, Gains from Investment Securities changed N/A year-over-year to $1.5 million; the trailing twelve-month figure through Dec 2018 stood at $2.6 million (changed N/A YoY), and the FY2020 full-year result was $226000.0, changed 0.0% from the prior year.
• Gains from Investment Securities grew to $1.5 million in Q4 2018, from $561000.0 in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $1.5 million in Q4 2018 to a low of $83000.0 in Q1 2018.